SPY319.34+7.98 2.56%
DIA271.54+8.21 3.12%
IXIC9,814.08+198.27 2.06%

vTv Therapeutics Q1 EPS $(0.110) Down From $(0.090) YoY

vTv Therapeutics (NASDAQ:VTVT) reported quarterly losses of $(0.110) per share. This is a 22.22 percent decrease over losses of $(0.090) per share from the same period last year.

Benzinga · 05/07/2020 21:30

vTv Therapeutics (NASDAQ:VTVT) reported quarterly losses of $(0.110) per share. This is a 22.22 percent decrease over losses of $(0.090) per share from the same period last year.